Invention Grant
![6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection](/docs/US/2017-05-02/US09637485B2/abs.jpg.600x600.jpg)
- Patent Title: 6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
-
Application No.: US14926393Application Date: 2015-10-29
-
Publication No.: US09637485B2Publication Date: 2017-05-02
- Inventor: Xingchun Han , Min Jiang , Jianhua Wang , Chengang Zhou , Yongguang Wang , Song Yang
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-LA Roche Inc.
- Current Assignee: Hoffmann-LA Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agent Jonathan Duffield
- Priority: WOPCT/CN2014/090156 20141103; WOPCT/CN2015/083939 20150714
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; C07D471/04
![6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection](/abs-image/US/2017/05/02/US09637485B2/abs.jpg.150x150.jpg)
Abstract:
The invention provides novel compounds having the general formula: wherein R1 to R6, W and X are as described herein and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
Public/Granted literature
Information query
IPC分类:
